4/A
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-22-017418
Director sold 2,500 shares at $30.80 ($77,000)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PIMSTONE SIMON N. Director | 2022-03-08 | Sale | −2,500 | $30.80 | $77,000 | 193,135 | D: show line 1 in the form |
| Open-market sales · 2,500 sh · avg $30.80 · $77,000 | |||||||
Loading xslF345X03/doc4a.xml…